Table of Contents: CATIE TreatmentUpdate

Table of Contents: CATIE TreatmentUpdate - 1999
Canadian AIDS Treatment Information Exchange
Edited by: Sean Hosein

TreatmentUpdate 103: December - Vol. 11, No. 9: Looking at T-cell counts and viral load in women; Weird vision problems with Serzone; Treating cocaine and heroin addiction; Aldra for mollusca?; Two immune boosters for HIV?
TreatmentUpdate 102: November - Vol. 11, No. 8: Vitamins can make a difference; Growth hormone for change in body shape; Desensitization to Nevirapine; Caution about mixing Viagra and Indinavir; Women and HIV: Body shape changes may be linked to virus; Treatment for TB; Cat's claw scratching away at the immune system?
TreatmentUpdate 101: October - Vol. 11, No. 7: Thinking of giving HAART a holiday; HAART takes a holiday; Triple therapy in AIDS; A link between CD4+ cell counts and drug resistance; Two years of HAART - effect on CMV
TreatmentUpdate 100: September - Vol. 11, No. 6: Nukes alone; Triple nuke therapy in France; IL-12 for hepatitis C; Treating Kaposi's sarcoma; Taxol may prolong remission of KS; New combination for brain cancer; Vanadium - help for blood sugar problems?; Problems falling asleep; Something doesn't taste right; Prozac and depression; Results of survey
TreatmentUpdate 99: August - Vol. 11, No. 5: Salvage therapy for indinavir and ritonavir users; Taking a break from therapy; Stopping HAART after one year; IL-2 study results in confusion; Vaccine therapy for hepatitis B?; Chinese herbs for CMV (cytomegalovirus); Famvir and interferon for hepatitis B?; Fluconazole and fungal infections; Weekly versus daily fluconazole to prevent fungal infections
TreatmentUpdate 98: June - Vol. 11, No. 4: Interrupting HAART for one month; From initial to salvage therapy: report from a clinic; Are changes in body shape due to drug side effects?; Body shape changes in women; Are changes in body shape linked to viral load?; Protease therapy and changes to insulin and glucose; Transfer therapy - nevirapine for protease problems?; Free radicals, antioxidants and HIV; NAC - boosting defenses against free radicals
TreatmentUpdate 97: May - Vol. 11, No. 3: Antiviral therapy in the real world; HIV eradication theory meets reality; Eradication timetable setback; Methadone does adjustment needed with nevirapine
TreatmentUpdate 96: April - Vol. 11, No. 2: The problems with antivirals alone; Why is IL-2 being considered? High-dose IL-2 without HAART; Two years of IL-2 in early HIV disease - fantastic increases in CD4+ cell counts; Penises and proteases; Ritonavir and periods; A warning about Viagra and HAART
TreatmentUpdate 95: February - Vol. 11, No. 1: Ritonavir/Saquinavir versus indinavir; HAART & IL-2 study a setback for eradication theory; Are echinacea and HIV not a good mix?; Discontinuing PCP prophylaxis under HAART; Mepron needs help to avoid resistance; Study finds NAC fails to prevent Bactrim/Septra hypersensitivity; Thyroid hormone levels affected by ritonavir
Copyright / Funding / How to reach CATIE

ÆGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1990,1999. ÆGiS & the Sisters of Saint Elizabeth of Hungary. All materials appearing on ÆGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of ÆGIS and the Sisters of Saint. Elizabeth of Hungary, or the party credited as the provider of the content. Please contact the party credited as the provider of the content for permission to reproduce.

Table Of Contents